Hydrochloric Acid → HCID 58356338, compound
Reaction equation
[N:1]1([CH2:7][C:8]2[S:9][CH:10]=[C:11]([C:13]([NH:15][C:16]3[CH:24]=[C:23]([C:25]4[CH:26]=[C:27]5[CH:33]=[N:32][N:31](S(C6C=CC=CC=6)(=O)=O)[C:28]5=[N:29][CH:30]=4)[CH:22]=[C:21]4[C:17]=3[CH:18]=[N:19][N:20]4S(C3C=CC=CC=3)(=O)=O)=[O:14])[N:12]=2)[CH2:6][CH2:5][O:4][CH2:3][CH2:2]1.[OH-].[Na+].Cl>C(O)(C)C>[N:1]1([CH2:7][C:8]2[S:9][CH:10]=[C:11]([C:13]([NH:15][C:16]3[CH:24]=[C:23]([C:25]4[CH:26]=[C:27]5[CH:33]=[N:32][NH:31][C:28]5=[N:29][CH:30]=4)[CH:22]=[C:21]4[C:17]=3[CH:18]=[N:19][NH:20]4)=[O:14])[N:12]=2)[CH2:2][CH2:3][O:4][CH2:5][CH2:6]1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
2-(4-Morpholinylmethyl)-N-{1-(phenylsulfonyl)-6-[1-(phenylsulfonyl)-1H-pyrazolo[3,4-b]pyridin-5-yl]-1H-indazol-4-yl}-1,3-thiazole-4-carboxamide (124 mg, 0.167 mmol) was suspended in Isopropanol (1 mL) and Sodium hydroxide (1 ml, 2.0 mmol) was added. The mixture was stirred at room temperature for 18 h. The mixture was neutralised with 2 M HCl (aq.) and the solvent was removed under a stream of nitrogen. The residue was dissolved in DMSO (2 ml) (insoluble salt was filtered off through a filter tube) and the samples (2×1 ml injections) were purified by mass directed autoprep HPLC (Method F). The product-containing fractions were concentrated under a stream of nitrogen to give the title compound as a cream solid (23 mg).
Workup
- customthe solvent was removed under a stream of nitrogen
- dissolutionThe residue was dissolved in DMSO (2 ml) (insoluble salt was filtered off through a filter tube)
- customthe samples (2×1 ml injections) were purified by mass
- concentrationThe product-containing fractions were concentrated under a stream of nitrogen
Sources & evidence
- ORD record
- ord-e5a66988f76d487cb91bba0415836e0b
- Source dataset
- uspto-grants-2014_02
- Patent number
- US08658635B2
Reaction notes
Loading…